[HTML][HTML] Cell-penetrating peptides in protein mimicry and cancer therapeutics
Extensive research has been undertaken in the pursuit of anticancer therapeutics. Many
anticancer drugs require specificity of delivery to cancer cells, whilst sparing healthy tissue …
anticancer drugs require specificity of delivery to cancer cells, whilst sparing healthy tissue …
[HTML][HTML] Applications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargos
The hydrophilic nature of peptides and proteins renders them impermeable to cell
membranes. Thus, in order to successfully deliver peptide and protein-based therapeutics …
membranes. Thus, in order to successfully deliver peptide and protein-based therapeutics …
Hypoxia: a double-edged sword in cancer therapy
H Manoochehri Khoshinani, S Afshar… - Cancer …, 2016 - Taylor & Francis
Hypoxia is a common feature of malignant tumors. There is an interactive connection
between hypoxia and chemoresistance, radioresistance, invasiveness, and angiogenesis …
between hypoxia and chemoresistance, radioresistance, invasiveness, and angiogenesis …
Tumor hypoxia: a target for selective cancer therapy
Tumor hypoxia has been considered to be a potential therapeutic problem because it
renders solid tumors more resistant to sparsely ionizing radiation (IR) and chemotherapeutic …
renders solid tumors more resistant to sparsely ionizing radiation (IR) and chemotherapeutic …
Delivery of bioactive molecules into the cell: the Trojan horse approach
In recent years, vast amounts of data on the mechanisms of neural de-and regeneration
have accumulated. However, only in disproportionally few cases has this led to efficient …
have accumulated. However, only in disproportionally few cases has this led to efficient …
Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer
JS Wadia, SF Dowdy - Advanced drug delivery reviews, 2005 - Elsevier
The direct intracellular delivery of proteins, or active peptide domains, has, until recently,
been difficult to achieve due primarily to the bioavailability barrier of the plasma membrane …
been difficult to achieve due primarily to the bioavailability barrier of the plasma membrane …
Protein transduction domain delivery of therapeutic macromolecules
A Van Den Berg, SF Dowdy - Current opinion in biotechnology, 2011 - Elsevier
Owing to their unprecedented selectivity, specific activity and potential for 1000+ fold
amplification of signal, macromolecules, such as peptides, catalytic protein domains …
amplification of signal, macromolecules, such as peptides, catalytic protein domains …
Cell penetrating peptides in drug delivery
EL Snyder, SF Dowdy - Pharmaceutical research, 2004 - Springer
Protein transduction domains (PTDs) are small cationic peptides that can facilitate the
uptake of large, biologically active molecules into mammalian cells. Recent reports have …
uptake of large, biologically active molecules into mammalian cells. Recent reports have …
Curb challenges of the “Trojan Horse” approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery
Abstract Cell-penetrating peptide (CPP)-mediated intracellular drug delivery system, often
specifically termed as “the Trojan horse approach”, has become the “holy grail” in achieving …
specifically termed as “the Trojan horse approach”, has become the “holy grail” in achieving …
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape
T Endoh, T Ohtsuki - Advanced drug delivery reviews, 2009 - Elsevier
RNAi-mediated silencing of specific genes is a promising strategy for gene therapy. To
utilize RNAi for therapy, an efficient and safe method for delivery of RNA into the cell cytosol …
utilize RNAi for therapy, an efficient and safe method for delivery of RNA into the cell cytosol …